Combined immunoexpression of Gal-3 and CK19 had 92% sensitivity and 99% specificity while combined positivity for Gal-3 and HBME-1 had 95% sensitivity and 95% specificity for papillary thyroid carcinoma (64). The gene discussed is KRT19; the disease is differentiated thyroid carcinoma.